Skip to content

the Effect of Wuling Capsule in Reducing Anxiety and Depression in Patients Undergoing Coronary Artery Bypass Grafting

the Effect of Wuling Capsule for Reducing Anxiety and Depression in Patients Undergoing Coronary Artery Bypass Grafting

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017989
Enrollment
Unknown
Registered
2018-08-25
Start date
2018-08-24
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

Group 1:wuling capsule
Group 2:NA

Sponsors

Beijing Anzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old male and female; 2. Diagnosed as CAD and planning to receive the CABG treatment, no matter what other procedure will be added simultaneously; 3. Signed an informed consent; 4. Competent to complete the questionnaire without any assistance.

Exclusion criteria

Exclusion criteria: 1. Patients who have been diagnosed the psychologic disorder and treated by medicine, such as anxiety and depression; 2. Patients who have the disability of recognition to express accurately; 3. Patients who is suffering the limb disability that can not complete the standard rehabilitation; 4. Patients who have received other clinical trial in recent 3 months; 5. The participant cannot follow the instruction judged by the investigators.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Rating Scale;

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale;

Countries

China

Contacts

Public ContactZhang Chunxiao

Beijing Anzhen Hospital

chunxiaozhangmd@outlook.com+86 15301018588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026